Grade @ or @ acne-like rash ( in @ of @ patients -LSB- @ % -RSB- vs four of @ -LSB- < @ % -RSB- ) , diarrhoea ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , mucositis ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) , and infusion-related reactions ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) were more frequent in patients treated with FOLFOX@ plus cetuximab than in those patients who received FOLFOX@ alone .